MILLION CITIES (02892) expects a significant reduction in post-tax losses and losses attributable to shareholders for the fiscal year 2025.
(02892) issued an announcement that for the fiscal year ending in 2025, the Group expects a post-tax loss ranging from RMB 20 million to RMB 29 million (for the fiscal year ending on December 31, 2024: RMB 143.5 million); and the equity shareholders of the Company are expected to incur a loss ranging from RMB 15 million to RMB 21 million (for the fiscal year ending in 2024: RMB 113.8 million).
Million Cities (02892) announced that for the fiscal year 2025, the group expects its post-tax loss to be between RMB 20 million and RMB 29 million (for the fiscal year ending December 31, 2024: RMB 143.5 million), and the loss attributable to equity shareholders of the company to be between RMB 15 million and RMB 21 million (for the fiscal year 2024: RMB 113.8 million).
For the fiscal year 2024, the company recognized impairment losses on other receivables from its joint ventures, and made provisions for accrued interest on its joint ventures. These impairment losses and provisions were not recognized or made in the fiscal year 2025. In addition, for the fiscal year 2025, the group obtained inventory impairment amounts from its subsidiaries and joint ventures, as well as significantly reducing administrative expenses and taxes compared to the fiscal year 2024, and reversing excess tax provisions made in previous fiscal years. Therefore, the company expects that its post-tax loss and the loss attributable to equity shareholders will significantly decrease for the fiscal year 2025.
Related Articles

Shanghai Fosun Pharmaceutical (02196): Sodium Thiosulfate Injection Approved for Registration

Yum China (09987) spent HK$7.712 million on March 19 to repurchase 18,200 shares.

XIAOMI-W (01810) spent 99.99 million Hong Kong dollars to repurchase 2.975 million shares on March 20th.
Shanghai Fosun Pharmaceutical (02196): Sodium Thiosulfate Injection Approved for Registration

Yum China (09987) spent HK$7.712 million on March 19 to repurchase 18,200 shares.

XIAOMI-W (01810) spent 99.99 million Hong Kong dollars to repurchase 2.975 million shares on March 20th.

RECOMMEND

State Reform Fund And Three Major Banks Backstop Voyah As It Secures Hong Kong’s First Auto IPO This Year
20/03/2026

Hong Kong IPO Irregularities Surface As Corner Placements And Retail Losses Emerge, Haizhi Technology Implicated
20/03/2026

Gold And Silver Experience Sharp Sell‑Off As Global Rate‑Hike Expectations Intensify
20/03/2026


